Merck & Co., Inc. (MRK) Financials

MRK Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 129.8 billion 87.8 billion
March 31, 2026 128.7 billion 82.8 billion
Dec. 31, 2025 136.9 billion 84.2 billion
Sept. 30, 2025 129.5 billion 77.6 billion

MRK Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 4.5 billion 298.0 million
March 31, 2026 2.9 billion 185.0 million
Dec. 31, 2025 1.8 billion 205.0 million
Sept. 30, 2025 6.8 billion 204.0 million

MRK Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 -1.3 billion
March 31, 2026 -4.2 billion
Dec. 31, 2025 3.0 billion
Sept. 30, 2025 5.8 billion

MRK Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 7.1 billion 51.1 billion -
March 31, 2026 5.7 billion 46.7 billion -
Dec. 31, 2025 14.6 billion 46.8 billion 901.0 million
Sept. 30, 2025 18.2 billion 40.0 billion -

MRK Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 2.5 billion
March 31, 2026 2.5 billion
Dec. 31, 2025 2.5 billion
Sept. 30, 2025 2.5 billion

MRK Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 893.0 million 9.7 billion 2.9 billion -
March 31, 2026 991.0 million 12.6 billion 2.7 billion -
Dec. 31, 2025 1.0 billion 2.5 billion 2.8 billion -
Sept. 30, 2025 987.0 million 3.6 billion 2.0 billion -

MRK Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 16.6 billion 4.4 billion
March 31, 2026 16.3 billion 2.9 billion
Dec. 31, 2025 16.3 billion 4.8 billion
Sept. 30, 2025 17.2 billion 4.2 billion

MRK Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MRK

Price: $150.69

52 week price:
75.81
152.55

Dividend Yield: 2.58%

5-year range yield:
2.23%
4.25%

Forward Dividend Yield: 2.23%

Payout Ratio: 57.04%

Payout Ratio Range:
-2291.07%
397.66%

Dividend Per Share: 3.40 USD

Earnings Per Share: 1.25 USD

P/E Ratio: 104.74

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 7.8 million

Ebitda: 2.3 billion

Market Capitalization: 323.0 billion

Average Dividend Frequency: 4

Years Paying Dividends: 65

DGR3: 5.57%

DGR5: 7.12%

DGR10: 6.54%

DGR20: 4.11%

Links: